Research & Clinical Trial News

View Our Trials

Understanding GDF15 and Its Role in Cancer‑Related Weight Loss

Weight loss and muscle wasting in cancer are more than just side effects of the disease. They can shorten survival, reduce energy, and make it harder for patients to receive or recover from treatments. Current options to slow or reverse this decline are limited. Research over the past decade has made it clear that GDF15 is one of the main triggers of appetite loss and wasting in cancer.

Read More

Astera Cancer Care Enrolls First Patient as First Community Site in Pioneering Clinical Trial

Astera Cancer Care is proud to announce that we have enrolled our first patient in a groundbreaking first-in-human (FIH) clinical trial, becoming the first community site in the United States to do so.

Read More

First Patient in the World Enrolled in IDeate-Lung02 Trial

Astera Cancer Care, an independent, physician-owned multi-specialty oncology practice, has yet again achieved another significant milestone by enrolling the world’s first patient in phase 3 of the IDeate-Lung02 clinical trial.

Read More

Astera Cancer Care Introduces ALPHA3 Clinical Trial

Astera Cancer Care has collaborated with Allogene Therapeutics to revolutionize the landscape of CAR T cell therapy, particularly for patients with Large B-Cell Lymphoma (LBCL).

Read More

The Beginning of a New Phase of Life

Fanni, 37, was 28 weeks pregnant when she was diagnosed with cancer. “I felt like my world ended at that moment,” Fanni recounts.

Read More